Liang Y, Wu H, Wei X
Front Oncol. 2024; 14:1374373.
PMID: 39165686
PMC: 11333883.
DOI: 10.3389/fonc.2024.1374373.
Agnello F, Cannella R, Brancatelli G, Galia M
Radiol Med. 2024; 129(11):1575-1586.
PMID: 39158817
DOI: 10.1007/s11547-024-01879-8.
Sharma K, Mohsin M, Mittal P, Ali Z, Fatma N, Upadhyay P
Curr Pharm Des. 2024; 30(22):1708-1724.
PMID: 38797901
DOI: 10.2174/0113816128298875240321073907.
Arefan D, DArdenne N, Iranpour N, Catania R, Yousef J, Chupetlovska K
Abdom Radiol (NY). 2024; 49(7):2220-2230.
PMID: 38782785
DOI: 10.1007/s00261-024-04344-2.
Dioguardi Burgio M, Garzelli L, Cannella R, Ronot M, Vilgrain V
Life (Basel). 2023; 13(12).
PMID: 38137868
PMC: 10744421.
DOI: 10.3390/life13122267.
Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues.
Marrone G, Leone M, Biolato M, Liguori A, Bianco G, Spoletini G
Cancers (Basel). 2023; 15(23).
PMID: 38067299
PMC: 10705300.
DOI: 10.3390/cancers15235593.
LI-RADS threshold growth based on tumor growth rate can improve the diagnosis of hepatocellular carcinoma ≤ 3.0 cm.
Jeong B, Choi S, Choi S, Jang H, Byun J, Won H
Eur Radiol. 2023; 34(2):1210-1218.
PMID: 37589898
DOI: 10.1007/s00330-023-10092-6.
Suboptimal performance of LI-RADS v2018 on gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in liver transplant candidates.
Oh N, Choi S, Kim S, Lee H, Jang H, Byun J
Eur Radiol. 2023; 34(1):465-474.
PMID: 37532900
DOI: 10.1007/s00330-023-10014-6.
Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis.
Rocha C, Doyle E, Bowman C, Fiel M, Stueck A, Goossens N
Cancer Med. 2023; 12(9):10175-10186.
PMID: 37078924
PMC: 10225173.
DOI: 10.1002/cam4.5711.
Improved diagnosis of histological capsule in hepatocallular carcinoma by using nonenhancing capsule appearance in addition to enhancing capsule appearance in gadoxetic acid-enhanced MRI.
Nishioka E, Sofue K, Maruyama K, Ueshima E, Ueno Y, Tsurusaki M
Sci Rep. 2023; 13(1):6113.
PMID: 37059750
PMC: 10104865.
DOI: 10.1038/s41598-023-33048-8.
Prospective evaluation of Gadoxetate-enhanced magnetic resonance imaging and computed tomography for hepatocellular carcinoma detection and transplant eligibility assessment with explant histopathology correlation.
Jhaveri K, Babaei Jandaghi A, Bhayana R, Elbanna K, Espin-Garcia O, Fischer S
Cancer Imaging. 2023; 23(1):22.
PMID: 36841796
PMC: 9960413.
DOI: 10.1186/s40644-023-00532-3.
Cancer tracking system improves timeliness of liver cancer care at a Veterans Hospital: A comparison of cohorts before and after implementation of an automated care coordination tool.
Zhang Y, Mezzacappa C, Shen L, Ivatorov A, Petukhova-Greenstein A, Mehta R
PLOS Digit Health. 2023; 1(8):e0000080.
PMID: 36812575
PMC: 9931271.
DOI: 10.1371/journal.pdig.0000080.
A Multi-centre, Single Arm, Non-randomized, Prospective European Trial to Evaluate the Safety and Efficacy of the HistoSonics System in the Treatment of Primary and Metastatic Liver Cancers (#HOPE4LIVER).
Wah T, Pech M, Thormann M, Serres X, Littler P, Stenberg B
Cardiovasc Intervent Radiol. 2022; 46(2):259-267.
PMID: 36380155
PMC: 9892119.
DOI: 10.1007/s00270-022-03309-6.
[Recent Updates of Abbreviated MRI for Hepatocellular Carcinoma Screening].
Kim J, Lee C
Taehan Yongsang Uihakhoe Chi. 2022; 82(2):280-297.
PMID: 36238735
PMC: 9431949.
DOI: 10.3348/jksr.2021.0025.
Interrater reliability and agreement of the liver imaging reporting and data system (LI-RADS) v2018 for the evaluation of hepatic lesions.
Abdelrahman A, Madkour S, Ekladious M
Pol J Radiol. 2022; 87:e316-e324.
PMID: 35892071
PMC: 9288199.
DOI: 10.5114/pjr.2022.117590.
The Course of LIRADS 3 and 4 Hepatic Abnormalities as Correlated With Explant Pathology: A Single Center Experience.
Mettikanont P, Kalluri A, Bittermann T, Phillips N, Loza B, Rosen M
J Clin Exp Hepatol. 2022; 12(4):1048-1056.
PMID: 35814502
PMC: 9257948.
DOI: 10.1016/j.jceh.2022.02.005.
The Promise of Magnetic Resonance Imaging in Radiation Oncology Practice in the Management of Brain, Prostate, and GI Malignancies.
Srinivasan S, Dasgupta A, Chatterjee A, Baheti A, Engineer R, Gupta T
JCO Glob Oncol. 2022; 8:e2100366.
PMID: 35609219
PMC: 9173575.
DOI: 10.1200/GO.21.00366.
From LI-RADS Classification to HCC Pathology: A Retrospective Single-Institution Analysis of Clinico-Pathological Features Affecting Oncological Outcomes after Curative Surgery.
Centonze L, De Carlis R, Vella I, Carbonaro L, Incarbone N, Palmieri L
Diagnostics (Basel). 2022; 12(1).
PMID: 35054327
PMC: 8775107.
DOI: 10.3390/diagnostics12010160.
Clinical application of advances and innovation in radiation treatment of hepatocellular carcinoma.
Tong V, Shelat V, Kuo Chao Y
J Clin Transl Res. 2022; 7(6):811-833.
PMID: 34988334
PMC: 8715712.
Measuring HCC Tumor Size in MRI-The Sequence Matters!.
Armbruster M, Guba M, Andrassy J, Rentsch M, Schwarze V, Rubenthaler J
Diagnostics (Basel). 2021; 11(11).
PMID: 34829348
PMC: 8623118.
DOI: 10.3390/diagnostics11112002.
